Quantcast Pharmaceutical Industry News - Congoo
Log In
  INDUSTRY >> PHARMACEUTICAL INDUSTRY    Get our Pharmaceutical Industry daily Briefing     
Advertising & marketing
Advertising industry
Aerospace & defense
Airline industry
Automotive industry
beverage related
Biological sciences
Book publishing
Broadcasting industry
Cable industry
Chemicals industry
Climate change
Clothing industry
Coal industry
Communications equipment
Computer games
Computer security
Computer services
Corporate finance
Corporate governance
Crime & Punishment
Database industry
Digital television
Drinks & beverage industry
Durable goods
Emerging markets
Engineering Industry
Enterprise computing
Equity markets
Fed watch
Finance related
Firearms industry
Food and drink
Food industry
Forex markets
Fund management
government: general
Graphics industry
Horse racing
Hospitality industry
Human resources
Human rights
Human sciences
Imaging equipment
Insurance industry
International development
International Paper Company
International relations
Internet news
IP and patents
Job markets
Knowledge management
Leisure goods
Mergers & acquisitions
Metals industry
Mining and metals
Mobile industry
Mortgage industry
Movie business
Music business
Mutual funds
Newspaper publishing
Oil & gas
Online access
Online broker
Online content
Online information
Online marketing
Online portals
Open source
OS news
Outdoor recreation
Packaging & paper
PC industry
PC software
Personal data privacy
Personal finance
Personal technology
Pharmaceutical Industry
Physical Sciences
Plastics industry
Pop music
Public health
Real Estate industry
Retail investor
Retail sector
Search Engines
Securities industry
Semiconductor industry
Shipping industry
Silicon Valley
Small business
Space science
Tech stocks
Telecom industry
television: general
Tobacco industry
Transportation industry
Travel & Vacation
Travel industry
US banking
US immigration
US politics
US security
US social policy
Utilities News
Venture Capital
Web developer
Wireless sector
XML & metadata

Clinical Trial Technology Firm ERT to Acquire PHT   - 24 Hours ago
- US-based clinical trial technology specialist ERT and US-based clinical research technology company PHT Corp. have signed a definitive agreement under which ERT will acquire PHT, the companies said

CEL-SCI Completes Key Milestone with Clearance to Conduct Phase III Trial in 21   - 2/27/2015
Belarus is 21st country to clear CEL-SCI's trial for patient enrollment VIENNA, Va.--(BUSINESS WIRE)--Feb. 27, 2015-- CEL-SCI Corporation (NYSE MKT: CVM) today announced the Ministry of Health of the

Is the future of pharma about making good drugs great?   - 2/27/2015
The cost of developing new drugs continues to soar. These days, drug developers can expect to shell out more than $2.5 billion to create a medicine, test it, and win regulatory approvals, according to

Is the future of pharma about making good drugs great?   - 2/27/2015

Doctor Panel to Weigh Hepatitis C Drugs’ Costs in Guidelines   - 2/27/2015
(Bloomberg) -- An influential advisory panel of doctors and health experts will for the first time address the cost-effectiveness of pricey hepatitis C drugs in updated guidelines that may change prescribing

Herantis Pharma does not expect any revenues in 2015   - 24 Hours ago
Thomson Reuters is the world's largest international multimedia news agency, providing investing news , world news , business news , technology news , headline news, small business news, news alerts,

Reach your target audience with AdBlade! Sponsored
- Brand your product
- Create awareness in your product
- Drive traffic

And do it all on a CPC basis of as little as 50 cents.  Try AdBlade and begin reaching your targ.  Learn More

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors   - 24 Hours ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TCP International Holdings Ltd. - TCPI PR Newswire NEW YORK, Feb. 27, 2015 NEW YORK , Feb. 27, 2015 /PRNewswire/

Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases   - 2/27/2015
SUNNYVALE, Calif., Feb. 27, 2015 /PRNewswire/ -- Pharmacyclics About Pharmacyclics Pharmacyclics, Inc. (NASDAQ: PCYC) is a biopharmaceutical company focused on developing and commercializing innovative
all 1 news articles >>

In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With   - 2/27/2015
SUNNYVALE, Calif., Feb. 27, 2015 /PRNewswire/ -- Pharmacyclics The paper's senior author, Ronald Levy, M.D., a professor of medicine and director of the lymphoma program at the Stanford University School
all 1 news articles >>

Your sponsored post can go right here! Sponsored

Congoo’s B2B information portal now receives over 1 million visits per month.  Congoo provides a highly influential audience comprehensive news and information within their industry.  Reach a coveted audience of senior executives, affluent males and opinion leaders. Get the Media Kit

Herbalife Falls After Ackman Stress Forces Another Forecast Cut   - 2/27/2015
(Bloomberg) -- Herbalife Ltd., facing an almost yearlong regulatory probe into its business practices, fell after cutting annual profit forecasts for the second straight quarter. The stock sank 9.2 percent

EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims against   - 2/27/2015
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims against Vitae Pharmaceuticals, Inc. – VTAE The Rosen Law Firm, P.A., a global investor rights firm, announces
all 1 news articles >>

U.S. Food and Drug Administration Accepts Biologics Licensing Application for Opdivo   - 2/27/2015
Opdivo has the potential to be the first Immuno-Oncology agent approved for the treatment of advanced squamous non-small cell lung cancer PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol-Myers Squibb
all 3 news articles >>

American Express takes you places Sponsored
The Preferred Rewards Gold Card takes you places. And shows you’ve arrived. Enjoy Gold Card benefits and access while you earn travel rewards fast. Earn 10,000 Membership Rewards® bonus points redeemable for rewards after your first purchase.  Learn More

Weight Watchers Shares Post Biggest Decline Since 2001 IPO   - 2/27/2015
(Updates with earnings forecast in fifth paragraph.) The company has faced declining subscriptions and revenue as consumers migrate to digital methods for counting calories and keeping in shape. Weight

Nanobiotix 2014 Q4 and Annual Revenues   - 2/27/2015
PARIS--(BUSINESS WIRE)--Feb. 27, 2015-- Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext: NANO ISIN: FR0011341205) a late clinical-stage nanomedicine company pioneering novel approaches for the local
all 1 news articles >>

Guaranteed Returns®, Pharmaceutical Returns Industry Founder,...   - 2/27/2015
Guaranteed Returns® Hires Corporate Counsel to Provide Corporate Governance for Pharmaceutical Return Operations Holbrook, New York (PRWEB) February 27, 2015 Guaranteed Returns® , founder of the

UPDATE 1-Sanofi diabetes drug Toujeo wins EU green light, pricing in focus   - 2/27/2015
6:39pm IST * European Medicines Agency recommends approval of Toujeo * Regulator highlights lower rate of hypoglycaemia * Pricing seen key in determining Toujeo take-up (Adds product details,
all 1 news articles >>

Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares   - 2/27/2015
HAMPTON, N.J., Feb. 27, 2015 (GLOBE NEWSWIRE) -- Celldex Therapeutics Jefferies LLC and Leerink Partners LLC are acting as the joint book-running managers and underwriters for the offering and Guggenheim
all 7 news articles >>

Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And   - 2/27/2015
POTTERS BAR, England and PITTSBURGH, Feb. 27, 2015 /PRNewswire/ -- Mylan Executive Chairman Robert J. Coury commented, "Today marks the beginning of the next exciting chapter of growth for Mylan. With
all 4 news articles >>

Bayer crown prince vows independence for diversified drugmaker   - 2/27/2015
Bayer CFO Werner Baumann poses during a news conference in Leverkusen February 28, 2012. Credit: Reuters/Ina Fassbender (Reuters) - Werner Baumann, seen as heir apparent to Bayer Chief Executive

Roche says EU agency recommends Avastin for cervical cancer   - 2/27/2015
10:19pm IST ZURICH (Reuters) - Roche said on Friday that European regulators had recommended approval of its drug Avastin in combination with chemotherapy as a treatment for women with an advanced
all 2 news articles >>

Encore Capital Group to Meet With the Investment Community at the Raymond James   - 2/27/2015
Your requested update has been submitted Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If
all 569 news articles >>

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors   - 24 Hours ago

The Salix–Valeant merger: Basics of Salix Pharmaceuticals   - 2/27/2015
Valeant makes yet another acquisition: Salix Pharmaceuticals (Part 4 of 12) ( Continued from Part 3 ) Basics of Salix Pharmaceuticals Salix Pharmaceuticals (SLXP) is a specialty pharmaceutical company

Online Petition to Lower Cancer Drug Prices in US   - 2/27/2015

Online Petition to Lower Cancer Drug Prices in US   - 2/27/2015
A leukemia expert and outspoken critic of the high prices charged for cancer drugs in the United States, who has repeatedly warned that the high prices are harming patients, is now mounting an online
*Votes may take up to 30 minutes to influence article rank order

Featured Members
John Caminis John Caminis
Vice President Clinical Development
Pharma Industry
Allison Gerard Allison Gerard
Research Director
Pharma Industry
George Green George Green
Sales Counselor
Pharma Industry
Frank Breve Frank Breve
President and CEO
Pharma Industry

  Add your Profile
  View more profiles


Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2015 Congoo.com. All Rights Reserved.